LexDanaLexDanabeta
Inventor

George N. Cox, III

Inventor
Louisville, CO, US

Overview

57→
Patents
2002–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 57 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
C07KPeptides26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C12NMicroorganisms or enzymes6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
A01KAnimal husbandry4%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture3%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology2%
PatentTitleYear
10,653,752Methods and use of growth hormone supergene family protein analogs for treatment of radiation exposure202010,508,131Cysteine analogs of exendin-4201910,329,337Method to increase the number of circulating platelets by administering PEGylated cysteine variants of IL-11201910,016,485Methods and use of growth hormone supergene family protein analogs for treatment of radiation exposure20189,637,530'Methods of preparing cysteine variants of human recombinant IL-11'20179,491,934'Regulation of endogenous gene expression in cells using zinc finger proteins'20169,320,777'Methods and use of growth hormone supergene family protein analogs for treatment of radiation exposure'20169,296,804'NH2-terminal glutamine modified cysteine variants of interferon gamma'20168,957,023'Methods for making proteins containing free cysteine residues'20158,932,828'Method for preparing recombinant granulocyte colony stimulating factor cysteine muteins'20158,859,497'Method of treatment using cysteine mutants of beta interferon'20148,748,392'Methods of treatment using cysteine variants of interleukin-11'20148,617,531'Methods of making proteins and peptides containing a single free cysteine'20138,618,256'Cysteine variants of interferon gamma'20138,455,434'Methods of use for cysteine variants of human G-CSF'20138,329,866'Long acting VEGF inhibitors and methods of use'20128,288,126'Methods for making proteins containing free cysteine residues'20128,268,618'Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins'20128,148,500'Method of preparing cysteine mutants of human recombinant GM-CSF'20128,133,480'Cysteine variants of interleukin-11'20127,994,124'Methods of use of G-CSF cysteine muteins'20117,985,887'Regulation of endogenous gene expression in cells using zinc finger proteins'20117,964,184'Cysteine variants of interferon-gamma'20117,959,909'Cysteine variants of interferon gamma'20117,947,655'Methods for making proteins containing free cysteine residues'20117,824,669'In vivo stimulation of peripheral blood progenitor cells by granulocyte-macrophage colony stimulating factor (GM-CSF) cysteine muteins and their PEGylated variants'20107,795,396'COOH-terminally added cysteine variant of the beta interferon'20107,788,044'Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites'20107,754,855'Immunoglobulin fusion proteins'20107,732,572'Cysteine variants of alpha interferon-2'20107,629,314'Methods for making proteins containing free cysteine residues'20097,560,101'Method of treatment of an infection in an animal with GM-CSF cysteine muteins in the proximal region to helix A'20097,495,087'Cysteine muteins in the C-D loop of human interleukin-11'20097,399,839'Monopegylated growth hormone proteins'20087,345,149'Cysteine substitution variants of beta interferon'20087,345,154'Cysteine variants of erythropoietin'20087,314,921'Cysteine variants of erythropoietin'20087,309,781'Cysteine variants of granulocyte colony-stimulating factor'20077,306,931'Method for refolding proteins containing free cysteine residues'20077,270,809'Cysteine variants of alpha interferon-2'20077,253,267'Cysteine variants of interleukin-11'20077,232,885'Termini cysteine-added variants of granulocyte colony stimulating factor'20077,214,779'Termini cysteine-added variants of granulocyte-macrophage colony stimulating factor'20077,177,766'Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites'20077,163,824'Regulation of endogenous gene expression in cells using zinc finger proteins'20077,153,943'Derivatives of growth hormone and related proteins, and methods of use thereof'20067,148,333'Cysteine variants of granulocyte-macrophage colony-stimulating factor'20067,070,934'Ligand-controlled regulation of endogenous gene expression'20067,013,219'Regulation of endogenous gene expression in cells using zinc finger proteins'20066,979,539'Regulation of endogenous gene expression in cells using zinc finger proteins'20056,824,978'Regulation of endogenous gene expression in cells using zinc finger proteins'20046,785,613'Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites'20046,753,165'Methods for making proteins containing free cysteine residues'20046,607,882'Regulation of endogenous gene expression in cells using zinc finger proteins'20036,608,183'Derivatives of growth hormone and related proteins'20036,534,261'Regulation of endogenous gene expression in cells using zinc finger proteins'20036,453,242'Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites'2002

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2002–2016Patents assigned to SANGAMO BIOSCIENCES INC (14)· patent assignee history
2002–2020Based in Louisville, CO, US· patent location history
2003–2020Patents assigned to BOLDER BIOTECHNOLOGY INC (42)· patent assignee history
2012–2016Patents assigned to COX GEORGE N (7)· patent assignee history
2012–2014Patents assigned to COX III GEORGE N (4)· patent assignee history
2012–2015Patents assigned to ROSENDAHL MARY S (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BOLDER BIOTECHNOLOGY INC422003–2020
SANGAMO BIOSCIENCES INC142002–2016
COX GEORGE Nself72012–2016
COX III GEORGE Nself42012–2014
ROSENDAHL MARY S42012–2015
Locations
LocationPatentsSpan
Louisville, CO, US572002–2020